Vit C for Pregnant Smokers May Improve Newborn Lung Function
Newborn lung function improved as measured by forced expiratory flow at three months of age
FDA Approves Drugs for Treatment of Two Rare Blood Diseases
Elzonris approved to treat BPDCN; Ultomiris approved for paroxysmal nocturnal hemoglobinuria
A-Fib Risk Up for Antidepressant Users, but Higher Before Tx
Antidepressant treatment linked to threefold increased risk during first month; link decreased over year
Incorrect Prescribing Alerts Common for Psychotropic Meds
One-third with electronic Rx system that provides alerts believe system provides incorrect warnings
FDA: Teething Jewelry Linked to at Least One Infant Death
Threats from these products include choking, strangulation, injury to the mouth, infection
FDA: Fluoroquinolones Tied to Heart Vessel Ruptures, Tears
Patients at risk include those with hypertension or certain genetic disorders and the elderly
Hospitalization for Upper GI Bleed Highest With Rivaroxaban
Upper gastrointestinal bleeding hospitalization risk lower for anticoagulant tx with PPI cotherapy
Pembrolizumab Promising for Metastatic Head, Neck SCC
Prolongs survival among patients with recurrent, metastatic head and neck squamous cell carcinoma
Sorafenib for Desmoid Tumors Ups Progression-Free Survival
Two-year progression-free survival rate 81 percent with sorafenib vs. 36 percent with placebo
ADA 2019 Standards of Care Emphasize Patient-Centered Care
Updates include use of SGLT-2 inhibitors and GLP-1 receptor agonists for T2DM, CVD; endorsed by ACC
